Updated: Oct 19, 2026

Gobind Singh's Stock Ratings

HC Wainwright & Co. Analyst

Gobind Singh is an analyst at HC Wainwright & Co.. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends.

Overall Average Return

-58.0%

Smart Score

19.5%

Overall Average Return Percentile

2nd

Number of Ratings

17
Buy NowGet Alert
09/08/2023RPHMBuy Now
Reneo Pharmaceuticals
—— → $30ReiteratesBuy → BuyGet Alert
08/28/2023RPHMBuy Now
Reneo Pharmaceuticals
—— → $30Initiates → BuyGet Alert
09/19/2022IMUXBuy Now
Immunic
$7.33254.71% → $26Assumes → BuyGet Alert
09/19/2022ANABBuy Now
AnaptysBio
$50.88-31.21% → $35Assumes → BuyGet Alert
09/19/2022RPHMBuy Now
Reneo Pharmaceuticals
—— → $31Assumes → BuyGet Alert
09/19/2022ELEVBuy Now
Elevation Oncology
—— → $7.5Assumes → BuyGet Alert
11/19/2021PRTABuy Now
Prothena Corp
$8.48808.02% → $77Initiates → Market OutperformGet Alert
11/15/2021PTGXBuy Now
Protagonist Therapeutics
$134.44-47.93%$60 → $70MaintainsMarket OutperformGet Alert
11/03/2021KLDOBuy Now
Kaleido Biosciences
$0.0021999900%$25 → $22MaintainsMarket OutperformGet Alert
11/02/2021EVLOBuy Now
Evelo Biosciences
$0.0020749900%$44 → $41.5MaintainsMarket OutperformGet Alert
10/13/2021PTGXBuy Now
Protagonist Therapeutics
$134.44-55.37%$47 → $60MaintainsMarket OutperformGet Alert
09/22/2021PTGXBuy Now
Protagonist Therapeutics
$134.44-65.04%$55 → $47MaintainsMarket OutperformGet Alert
06/23/2021EVLOBuy Now
Evelo Biosciences
$0.0018999900%$36 → $38MaintainsMarket OutperformGet Alert
05/24/2021PTGXBuy Now
Protagonist Therapeutics
$134.44-64.3% → $48Initiates → Market OutperformGet Alert
03/24/2021IMUXBuy Now
Immunic
$7.33650.34% → $55Initiates → Market OutperformGet Alert
12/23/2020EVLOBuy Now
Evelo Biosciences
$0.0013499900% → $27Initiates → OutperformGet Alert
12/23/2020KLDOBuy Now
Kaleido Biosciences
$0.0021999900% → $22Initiates → OutperformGet Alert